Hera Therapeutics Inc.

Amendment
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Sep 5, 2013
Total Offering

$1,126,006

Amount Sold

$1,126,006

Investors

18

First Sale

Feb 26, 2013

Offering Details

Type
Equity
Exemptions
Rule 506
Entity Type
Corporation
Year Incorporated
2012
Non-Accredited Investors
No

Related Persons

NameRole
Karl Y Hostetler
Related Person
William Respess
Related Person
Michael J Sullivan
Related Person
Michael D. Cannon
Related Person

Company

Antiva Biosciences, Inc.

14024 RUE SAINT RAPHAEL

DEL MAR, CA, 92014

415 983 1000

SEC Filing

0001563355-13-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free